שיטה דו-שלבית לליתוטומיה כולדוכוסקופית מלעורית טרנסה-כבדית

Executive Industry Relevance

This two-step percutaneous transhepatic choledochoscopic lithotomy (PTCSL) method addresses a critical unmet need in biliary surgery by improving stone clearance rates and reducing procedural complexity in patients with complex anatomical challenges or prior surgical history. The technique enhances procedural predictability and shortens intervention timelines, supporting risk-adjusted decision-making in hepatobiliary interventions. Its adaptability to percutaneous nephrolithotomy further demonstrates cross-platform utility in minimally invasive stone management.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables functional validation of biliary tract models by achieving complete stone clearance in preclinical simulation systems.
• Operational Value: Provides a reproducible interventional workflow for testing device efficacy and safety in biliary access platforms.

Screening & Assay Development

• Scientific Value: Facilitates standardized biliary duct access for evaluating lithotripsy devices and irrigation systems under controlled pressure conditions.
• Operational Value: Supports assay readiness through stable sinus tract formation and consistent drainage tube placement, reducing variability in preclinical models.

Translational & Preclinical Research

• Scientific Value: Bridges discovery to preclinical validation by enabling longitudinal assessment of biliary patency and stone recurrence in disease-relevant models.
• Operational Value: Allows iterative intervention testing through staged procedures, supporting risk-adjusted advancement of biliary therapeutics.

Pipeline & Workflow Integration

The method integrates into the interventional development continuum from early device testing to preclinical validation, particularly for biliary access and stone clearance technologies.

• Discovery Biology: Supports hypothesis testing of biliary duct patency and stone fragmentation efficacy in ex vivo and in vivo models.
• Screening: Enables standardized evaluation of irrigation pressure systems and stone retrieval devices through reproducible tract establishment.
• Analytics: Provides quantitative endpoints such as operation time, stone clearance rate, and recurrence frequency for comparative device assessment.
• Translational Research: Connects early feasibility to preclinical durability by modeling postoperative drainage and tract maturation.
• Enterprise Reuse: Establishes a reusable platform for iterative testing of biliary access sheaths, dilators, and endoscopic tools across multiple intervention cycles.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in biliary device performance by achieving high first-pass stone clearance rates.
• Operational Value: Enhances reproducibility through standardized preoperative drainage and sinus tract maturation steps.
• Strategic Value: Reduces iterative procedure burden, lowering resource consumption and accelerating preclinical timelines.
• Portfolio Impact: Enables risk-stratified advancement of biliary interventions based on procedural success and safety profiles.

Implementation Considerations

• Requires expertise in percutaneous biliary access and tract dilation techniques.
• Dependent on fluoroscopy-guided placement of 16F sheaths and drainage tubes.
• Necessitates coordination between interventional radiology and endoscopic teams for procedural sequencing.
• Adaptation across models requires scalable dilator systems and adjustable pressure irrigation capabilities.
• Limited by patient-specific biliary anatomy and preoperative ductal inflammation affecting tract stability.

Biopharma FAQs